Evaluating the effect of intraoperative dextrose 10% administration on reducing post-operative nausea and vomiting after laparoscopic surgery.

intraoperative dextrose to reduce post-operative nausea and vomiting.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201808847015879

Enrollment

130

Registered

2018-08-13

Start date

2018-08-18

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anaesthesia

Interventions

antiemetic medication

placebo

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: non smoker ASA I, II female 20-40 years of age undergoing laparoscopic surgery

Exclusion criteria

Exclusion criteria: morbid obesity severe hypertension congestive heart failure coagulopathy significant hepatic or renal disease diabetes mellitus, abnormal blood glucose on the morning of surgery withdrawal of consent severe intraoperative hypotension requiring large volume intravascular fluid treatment whose operations were prolonged (more than 2 h) random blood sugar elevated to > or = 200 mg% previous history of postoperative nausea and vomiting (PONV) currently receiving steroids or antiemetics pregnant or menstruating

Design outcomes

Primary

Measure	Time frame
to compare the incidence and severity of postoperative nausea and vomiting in study groups	—

Secondary

Measure	Time frame
anti emetic medication consumption,blood glucose changes between groups	—

Countries

Egypt

Contacts

Public Contactdalia fahmy

lecturer of anesthesia ain shams university

daliafahmy78@gmail.com+201005183655

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026